share_log

Jefferies Initiates Coverage On Orchestra BioMed Hldgs With Buy Rating, Announces Price Target of $14

Jefferies Initiates Coverage On Orchestra BioMed Hldgs With Buy Rating, Announces Price Target of $14

傑富瑞以買入評級開始對Orchestra BioMed Hldgs進行報道,宣佈目標股價爲14美元
Benzinga ·  01/19 19:28

Jefferies analyst Matthew Taylor initiates coverage on Orchestra BioMed Hldgs (NASDAQ:OBIO) with a Buy rating and announces Price Target of $14.

傑富瑞分析師馬修·泰勒開始對Orchestra BioMed Hldgs(納斯達克股票代碼:OBIO)進行報道,評級爲買入,並宣佈目標股價爲14美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論